Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cofact for reduction of transfusion during orthotopic liver transplantation
NL-OMON40112Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of Human prothrombin complex in Bleeding (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Number of red blood cell units transfused during and immediately after liver transplantation. Started Apr 2013; status: active, not recruiting.
02
Drugs
Human prothrombin complex
03
Conditions
Bleeding
Beyond the preview
Go deeper on NL-OMON40112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40112.